![](/img/cover-not-exists.png)
Biodistribution and dosimetry results from a phase 1 trial of 177 Lu-lilotomab satetraxetan antibody-radionuclide conjugate therapy
Blakkisrud, Johan, Holtedahl, Jon Erik, Løndalen, Ayca, Dahle, Jostein, Bach-Gansmo, Tore, Holte, Harald, Nygaard, Stine, Kolstad, Arne, Stokke, CarolineLanguage:
english
Journal:
Journal of Nuclear Medicine
DOI:
10.2967/jnumed.117.195347
Date:
August, 2017
File:
PDF, 1.14 MB
english, 2017